MTP XIV: Lymphoma 2  

Session Chair: Jorge J. Castillo, MD

• NK/T Cell Lymphoma | Won Seog Kim, MD, PhD | Samsung Medical Center, Seoul, Korea
• How Good Are Bispecifics in Marginal Zone Lymphoma? | Narendranath Epperla, MD, MS, FACP | Huntsman Cancer Institute, Salt Lake City, Utah, USA
• BTK Inhibitors in LPL and MZL: What Does the Data Tell Us? | Jorge J. Castillo, MD | Dana-Farber Cancer Institute, Boston, Massachusetts, USA